DarioHealth (NASDAQ:DRIO) Stock Price Up 1.9%

DarioHealth Corp (NASDAQ:DRIO) shares rose 1.9% during trading on Wednesday . The company traded as high as $11.25 and last traded at $7.61, approximately 8,812 shares traded hands during mid-day trading. A decline of 48% from the average daily volume of 16,789 shares. The stock had previously closed at $7.47.

A number of equities research analysts have weighed in on DRIO shares. Craig Hallum lowered their price target on DarioHealth from $20.00 to $12.00 and set a “buy” rating on the stock in a research report on Wednesday. ValuEngine upgraded DarioHealth from a “buy” rating to a “strong-buy” rating in a report on Tuesday.

The stock has a 50-day moving average of $1.47 and a two-hundred day moving average of $0.71. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.70 and a quick ratio of 1.35.

DarioHealth (NASDAQ:DRIO) last issued its earnings results on Monday, October 28th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.09) by $0.03. DarioHealth had a negative return on equity of 325.50% and a negative net margin of 248.57%. The business had revenue of $1.87 million during the quarter.

An institutional investor recently bought a new position in DarioHealth stock. Verition Fund Management LLC acquired a new stake in DarioHealth Corp (NASDAQ:DRIO) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 308,334 shares of the company’s stock, valued at approximately $143,000. Verition Fund Management LLC owned approximately 0.71% of DarioHealth as of its most recent filing with the SEC.

DarioHealth Company Profile (NASDAQ:DRIO)

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device.

Featured Article: Can systematic risk be avoided?

Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.